Product Information
DESVENLAFAXINE SUCCNT ER 25 MG is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.3985 per EA under NDC 70436003604. Its NADAC has been published 292 times since Mar 3, 2021.
FDA first approved this application on Oct 1, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436003604
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DESVENLAFAXINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA210014FDA Approved
10/1/2018
TE Code
AB
On Market Since
1/5/2021
Pharmacological Classes
Price Statistics
The NADAC for DESVENLAFAXINE SUCCNT ER 25 MG has been published 292 times since Mar 3, 2021, and over the history we have for it it has declined 47.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3985 per EA |
|---|---|
| All-time high | $0.8003 (Apr 14, 2021) |
| All-time low | $0.3565 (Nov 20, 2024) |
| 52-week high | $0.4592 |
| 52-week low | $0.3985 |
| Median price | $0.5045 |
| Average price | $0.5338 |
| Largest weekly change | +36.5% (Aug 21, 2024) |
| Weeks tracked | 292 |
| Tracking since | Mar 3, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Slate Run Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desvenlafaxine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESVENLAFAXINE SUCCNT ER 25 MG?
The current National Average Drug Acquisition Cost (NADAC) for DESVENLAFAXINE SUCCNT ER 25 MG, manufactured by Slate Run Pharmaceuticals LLC, is $0.3985 per EA (NDC 70436003604), effective Sep 30, 2026.
How has the price of DESVENLAFAXINE SUCCNT ER 25 MG changed over time?
Over the history we have for it, the NADAC for DESVENLAFAXINE SUCCNT ER 25 MG has declined 47.3%. It has been tracked across 292 weekly CMS publications since Mar 3, 2021.
What are the highest and lowest recorded NADAC prices for DESVENLAFAXINE SUCCNT ER 25 MG?
Since Mar 3, 2021, the NADAC for DESVENLAFAXINE SUCCNT ER 25 MG has ranged from a low of $0.3565 (Nov 20, 2024) to a high of $0.8003 (Apr 14, 2021), with a median of $0.5045 per EA.
Are there cheaper alternatives to DESVENLAFAXINE SUCCNT ER 25 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DESVENLAFAXINE SUCCNT ER 25 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures DESVENLAFAXINE SUCCNT ER 25 MG?
DESVENLAFAXINE SUCCNT ER 25 MG (NDC 70436003604) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.